Glycine Transporter (GlyT) inhibitors are compounds that block the reuptake of glycine, an important inhibitory neurotransmitter in the spinal cord and brainstem. By inhibiting glycine transporters, these compounds increase the availability of glycine in the synaptic cleft, enhancing its inhibitory effects on neuronal activity. GlyT inhibitors are of interest for their potential therapeutic applications in conditions like chronic pain, spasticity, and schizophrenia. At CymitQuimica, we provide GlyT inhibitors to support your research in pain management, motor control, and neuropsychiatric disorders.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.